[Federal Register Volume 81, Number 36 (Wednesday, February 24, 2016)]
[Notices]
[Pages 9219-9220]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03853]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Cedarburg 
Pharmaceuticals, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Cedarburg Pharmaceuticals, Inc. applied to be registered as a 
manufacturer of certain basic classes of controlled substances. The 
Drug Enforcement Administration (DEA) grants Cedarburg Pharmaceuticals, 
Inc. registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated September 16, 2015, and 
published in the Federal Register on September 23, 2015, 80 FR 57390, 
Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 
53024 applied to be registered as a manufacturer of certain basic 
classes of controlled substances. No comments or objections were 
submitted for this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Cedarburg Pharmaceuticals, Inc. to 
manufacture the basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the following basic classes of controlled substances:

[[Page 9220]]



------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
4-Anilino-N-phenethyl-4-piperidine (ANPP)    II
 (8333).
Remifentanil (9739)........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers. In reference to 
drug code 7360, marihuana, the company plans to bulk manufacture 
cannabidiol as a synthetic intermediate. This controlled substance will 
be further synthesized to bulk manufacture a synthetic 
tetrahydrocannabinols (7370). No other activity for this drug code is 
authorized for this registration.

    Dated: February 16, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-03853 Filed 2-23-16; 8:45 am]
 BILLING CODE 4410-09-P